arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

ARTELO BIOSCIENCES, INC.

ARTL

$0.74 ▼ -0.03 (-4.01%) at close

12 Visible periods

19 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Neutral Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, ARTELO BIOSCIENCES, INC. shows mixed fundamentals. Return on Invested Capital remain bright spots. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 708.3% ↗

FCF / Share None

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

12-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-12.88M

↓ -31.1% —

FCF / Share Free cash flow per share

$-1.29

↓ -2.0% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

Return on Invested CapitalReturn on Invested Capital of 708.3% is excellent on an absolute basis (target > 10%)

warning

Bearish Risks

Interest CoverageInterest Coverage of -58.78x is weak on an absolute basis (target > 5x)
FCF / Net IncomeFCF / Net Income of 0.66x is weak on an absolute basis (target > 1x)

Health Breakdown

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗
EPS Growth YoY (%)	—	—	—	—	—	—	45.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-31.1% Weak ↓ Weak Declining Year-over-year change in net income	-5.8% Weak ↑ Weak Improving Year-over-year change in net income	7.9% Fair ↑ Fair Improving Year-over-year change in net income	-35.6% Weak ↑ Weak Improving Year-over-year change in net income	-59.8% Weak ↑ Weak Improving Year-over-year change in net income	-114.3% Weak ↑ Weak Improving Year-over-year change in net income	7.3% Fair ↑ Fair Improving Year-over-year change in net income	-897.7% Weak ↓ Weak Declining Year-over-year change in net income	-691.1% Weak ↓ Weak Declining Year-over-year change in net income	-94.8% Weak Weak Year-over-year change in net income	0.2% Caution Caution Year-over-year change in net income	—
FCF Growth YoY (%)	—	—	—	—	—	—	-2.0% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗
FCF / Net Income (x)	0.66x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.29x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗
Return on Invested Capital (%)	708.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-279.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-66.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-41.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-48.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-95.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-46.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	1371.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-33.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	170.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-78.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-81.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%
Return on Capital (%) (%)	-407.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-215.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-76.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-50.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-58.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-107.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-49.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-590.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-40.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-827.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-89.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-103.7% Weak Weak Operating profit relative to total assets Optimal: > 10%
Return on Common Equity (%) (%)	—	—	-79.0% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-627%)	-52.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-446%)	-61.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-512%)	-120.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-901%)	-39.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-365%)	—	-43.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-387%)	215.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1334%)	-99.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-765%)	-103.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-791%)

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗
Interest Coverage (x)	-58.78x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-2057.40x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	-110.85x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-600.00K	—	—	$-6.89M	$-6.63M	$-2.14M	$-4.42M	$-337.42K	$-572.77K	$-3.59K	$-17.03K	$-14.73K

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗
Basic EPS, GAAP (USD)	—	—	—	—	—	—	$-1.00	$-1.84	—	—	—	—
Free Cash Flow per Share (USD)	—	—	—	—	—	—	$-1.29	$-1.26	—	—	—	—
Book Value per Share (USD)	$-0.63	$5.03	$3.69	$6.79	$7.36	$0.78	$1.63	$-0.08	$0.05	$-0.00	$0.00	$0.00
Tangible Book Value per Share (USD)	$-1.64	$1.44	$3.05	$6.08	$6.12	$0.37	$1.02	$-0.08	$0.05	$-0.00	$0.00	$0.00
Basic Weighted Avg Shares (shares)	—	—	—	—	—	—	2.17M	1.28M	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗
Working Capital (USD)	$-3.35M	$785.00K	$9.69M	$17.32M	$9.79M	$1.84M	$3.42M	$-135.54K	$544.84K	$-13.80K	$15.29K	—
Total Equity (USD)	$-1.27M	$2.86M	$11.75M	$19.40M	$12.04M	$3.87M	$5.46M	$-134.97K	$544.84K	$-13.80K	$15.29K	$14.73K

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Aug 31, 2021 10-K ↗	FY 2020 Aug 31, 2020 10-K ↗	FY 2019 Aug 31, 2019 10-K ↗	FY 2018 Aug 31, 2018 10-K ↗	FY 2017 Aug 31, 2017 10-K ↗	FY 2016 Aug 31, 2016 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗
Depreciation Expense (USD)	—	—	—	—	—	$500.00	$510.00	$282.00	—	—	—	—
Net Income, GAAP (USD)	$-12.88M	$-9.83M	$-9.29M	$-10.08M	$-7.44M	$-4.65M	$-2.17M	$-2.34M	$-234.89K	$-29.69K	$-15.24K	$-15.27K
Operating Cash Flow (USD)	$-8.52M	$-8.35M	$-8.21M	$-8.01M	$-6.14M	$-4.35M	$-2.79M	$-1.61M	$-216.82K	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 12 years · 49 quarters

ARTELO BIOSCIENCES, INC.

Analytical Summary

12-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare ARTL with peers